These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18620895)

  • 1. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).
    Laimer K; Blassnig N; Spizzo G; Kloss F; Rasse M; Obrist P; Schäfer G; Perathoner A; Margreiter R; Amberger A
    Oral Oncol; 2009 Feb; 45(2):127-34. PubMed ID: 18620895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
    Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
    Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
    Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
    Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M; Abt E; Stockinger M; Kunkel M
    Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
    BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of p53 immunoexpression with different clones (DO-7 and PAb-240) in oral squamous cell carcinoma.
    Silva Júnior Jde A; Camisasca DR; Bernardo V; Ribeiro GS; Dias FL; de Faria PA; de Amorim LM; Lourenço SQ
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(2):82-90. PubMed ID: 23817043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
    Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
    Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
    Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
    Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma.
    Chu PY; Liou JH; Lin YM; Chen CJ; Chen MK; Lin SH; Yeh CM; Wang HK; Maa MC; Leu TH; Chang NW; Hsu NC; Yeh KT
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e77-81. PubMed ID: 22897151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
    Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K; Kawashima Y; Yoshida H; Sato M
    Anticancer Res; 2006; 26(2B):1615-9. PubMed ID: 16619581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
    Nariai Y; Mishima K; Yoshimura Y; Sekine J
    Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.